The success of drugs like Keytruda is reshaping the pharmaceutical industry's competitive landscape. Merck & Co., Keytruda's manufacturer, has seen its overall revenue increase to 60.1 billion in 2023, driven largely by its oncology franchise. The company's commitment to innovation is evident in ...
U.S. biopharmaceutical export volume 2002-2023 Further Content:You might find this interesting as well Statistics U.S. top 10 prescribed drugs based on market share 2019 Patented drug 2022 sales share distribution by date of first NOC Patent drug sales impact on change in expenditure by therapy...
The quickest, most efficient way for mastering critical facts about common drugs Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs. ...
This version includes a limited amount of prescription drugs and resources. Upgrade to the Premium version with a one-time, in-app purchase that includes lifetime access to crucial information about the top 300 prescription drugs, including: • Generic and common name • Class • Dosage ...
目前已有多家托吡酯仿制药在美获批上市,如PAR PHARM以及ACTAVIS LABS FL等企业。此前Zydus就和Supernus签署了一项和解协议,允许其仿制药在2023年元旦进入市场,但Zydus的托吡酯首仿药获批不久后便处于撤市状态。 参考资料 [1]https://www.fiercepharma.com/special-reports/top-10-drugs-losing-us-exclusivity-2023...
目前已有多家托吡酯仿制药在美获批上市,如PAR PHARM以及ACTAVIS LABS FL等企业。此前Zydus就和Supernus签署了一项和解协议,允许其仿制药在2023年元旦进入市场,但Zydus的托吡酯首仿药获批不久后便处于撤市状态。 参考资料 [1]https://www.fiercepharma.com/special-reports/top-10-drugs-losing-us-exclusivity-2023...
MEDICAREThe article focuses on critiquing a recent study that assessed the added therapeutic benefit of top-selling brand-name drugs in Medicare, arguing that the analysis imported value judgments from other countries and failed to evaluate the therapeutic value to U.S. beneficiaries...
小编列出了药理学与药剂学(PHARMACOLOGY & PHARMACY)领域Top1-150的期刊信息供大家参考。 如您没有对我们公众号设为星标,也很少点在看,权重会降的非常低,有可能看不到我们的推文内容了。 将“大品种联盟”公众号设为星标⭐ 看完文章,在文末右下角给我们点...
However, with reduced attention on COVID-19, sales of Comirnaty have sharply declined. In 2023, Pfizer announced a 500% price increase for the Comirnaty; however, the price hike has proven insufficient to address the downturn in product sales. On October 13th, Pfizer announced plans to cut...
Brands with a score of 85 or higher received a Gold award. Brands that were statistically tied with the winner but had a score lower than 85 received a Silver award. Tags: health, medicine, women's health, men's health, products, drugs, generic drugs, over the counter drugs, NSAIDs...